1. 1) Arnold MM, Sen A, Greenberg HB, Patton JT. The battle between Rrotavirus and its host for control of the interferon signaling pathway. PLOS Pathog., 9, e1003064 (2013).
2. 2) Ueda N. Gastroduodenal perforation and ulcer associated with rotavirus and norovirus infections in Japanese children: a case report and comprehensive literature review. Open Forum Infect. Dis., 3, ofw026 (2016).
3. 3) Yin Y, Wang Y, Dang W, Xu L, Su J, Zhou X, Wang W, Felczak K, van der Laan LJ, Pankiewicz KW, van der Eijk AA, Bijvelds M, Sprengers D, de Jonge H, Koopmans MP, Metselaar HJ, Peppelenbosch MP, Pan Q. Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development. Antiviral Res., 133, 41–49 (2016).
4. 4) Chiappini E, Azzari C, Moriondo M, Galli L, de Martino M. Viraemia is a common finding in immunocompetent children with rotavirus infection. J. Med. Virol., 76, 265–267 (2005).
5. 5) Muhsen K, Anis E, Rubinstein U, Kassem E, Goren S, Shulman LM, Ephros M, Cohen D. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011–2015: a case-control study. Clin. Microbiol. Infect., 24, 53–59 (2018).